Solasta Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Maxion Therapeutics raises £58m in Series A led by General Catalyst to advance KnotBody pipeline

17 Mar 2025

Maxion Therapeutics raises £58m in Series A led by General Catalyst to advance KnotBody pipeline

Maxion Therapeutics develops antibody-based KnotBody drugs targeting ion channels and GPCRs, advancing new treatments for inflammatory, pain and cardiovascular diseases with improved selectivity.

Solasta Ventures

- Life Sciences
solasta-ventures.com
Update Information

More venture news

Astral Systems
23 Jun 2026
Astral Systems unlocks £23m Series A led by Mercia Ventures to develop medical isotopes with multi-state fusion technology
Series ADeep Tech
Superlight
22 Jun 2026
Superlight secures £16m Series A led by Engine Ventures and 2150 to manufacture electric commercial vehicles for middle mile logistics
Series AMobility
Isometric
22 Jun 2026
Isometric raises £30m in a Series A led by AVP to automate industrial certification with AI agents
Series AIndustrial

Solasta Ventures

Investment Portfolio

Maxion Therapeutics raises £58m in Series A led by General Catalyst to advance KnotBody pipeline

More venture news

Astral Systems unlocks £23m Series A led by Mercia Ventures to develop medical isotopes with multi-state fusion technology

Superlight secures £16m Series A led by Engine Ventures and 2150 to manufacture electric commercial vehicles for middle mile logistics

Isometric raises £30m in a Series A led by AVP to automate industrial certification with AI agents